Choreo LLC Purchases 911 Shares of Danaher Co. (NYSE:DHR)

Choreo LLC increased its position in shares of Danaher Co. (NYSE:DHR) by 4.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 21,703 shares of the conglomerate’s stock after buying an additional 911 shares during the period. Choreo LLC’s holdings in Danaher were worth $4,984,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Tectonic Advisors LLC boosted its stake in Danaher by 7.6% during the fourth quarter. Tectonic Advisors LLC now owns 3,350 shares of the conglomerate’s stock worth $769,000 after buying an additional 238 shares in the last quarter. Nvwm LLC lifted its holdings in shares of Danaher by 1.6% during the 4th quarter. Nvwm LLC now owns 5,592 shares of the conglomerate’s stock worth $1,284,000 after acquiring an additional 89 shares during the period. Confluence Wealth Services Inc. boosted its position in shares of Danaher by 4.3% during the 4th quarter. Confluence Wealth Services Inc. now owns 2,904 shares of the conglomerate’s stock valued at $713,000 after acquiring an additional 120 shares in the last quarter. Osprey Private Wealth LLC increased its stake in Danaher by 1.1% in the fourth quarter. Osprey Private Wealth LLC now owns 11,250 shares of the conglomerate’s stock valued at $2,582,000 after acquiring an additional 125 shares during the period. Finally, Stratos Investment Management LLC raised its position in Danaher by 19.7% in the fourth quarter. Stratos Investment Management LLC now owns 1,618 shares of the conglomerate’s stock worth $371,000 after purchasing an additional 266 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Guggenheim started coverage on Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective on the stock. JPMorgan Chase & Co. lowered their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Jefferies Financial Group cut their price objective on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. Barclays lowered their target price on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Finally, Stifel Nicolaus lifted their price target on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Price Performance

NYSE:DHR opened at $211.92 on Thursday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The firm has a market cap of $153.07 billion, a price-to-earnings ratio of 40.14, a P/E/G ratio of 2.80 and a beta of 0.83. Danaher Co. has a 52 week low of $210.04 and a 52 week high of $281.70. The firm’s 50-day simple moving average is $234.50 and its 200 day simple moving average is $252.68.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the firm posted $2.09 earnings per share. As a group, sell-side analysts predict that Danaher Co. will post 7.77 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.51%. Danaher’s dividend payout ratio (DPR) is 20.45%.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 10.90% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.